Stenmark; Paul
Patent Applications and Registrations
Patent applications and USPTO patent grants for Stenmark; Paul.The latest application filed is for "novel botulinum neurotoxin and its derivatives".
- Stenmark; Paul - Stockholm SE
| Patent | Date |
|---|---|
| Novel Botulinum Neurotoxin And Its Derivatives App 20220177867 - Dong; Min ; et al. | 2022-06-09 |
| Botulinum neurotoxin and its derivatives Grant 11,286,473 - Dong , et al. March 29, 2 | 2022-03-29 |
| Botulinum neurotoxin and its derivatives Grant 11,248,218 - Dong , et al. February 15, 2 | 2022-02-15 |
| Engineered botulinum neurotoxins Grant 11,104,891 - Dong , et al. August 31, 2 | 2021-08-31 |
| Neurotoxin-like Toxin And Uses Thereof App 20200255481 - Kind Code | 2020-08-13 |
| A Novel Botulinum Neurotoxin And Its Derivatives App 20200224185 - Dong; Min ; et al. | 2020-07-16 |
| Engineered Botulinum Neurotoxins App 20190300869 - Dong; Min ; et al. | 2019-10-03 |
| A Novel Botulinum Neurotoxin And Its Derivatives App 20190136216 - Dong; Min ; et al. | 2019-05-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 